Commit To Purchase Navidea Biopharmaceuticals At $1, Earn 11.6% Annualized Using Options
May 11, 2015 at 11:34 AM EDT
Investors eyeing a purchase of Navidea Biopharmaceuticals, Inc. (NAVB) shares, but cautious about paying the going market price of $1.29/share, might benefit from considering selling puts among the alternative strategies at their disposal..